Related Experiment Videos
Renal and hepatic interactions of acetaminophen and amikacin in the infant rat
M E Meléndez Camargo1, M Lozano Cortés
1Department of Pharmacy, Escuela Nacional de Ciencias Biológicas, México, D.F., México.p6
Proceedings of the Western Pharmacology Society
|December 4, 1998
Insights
High-dose amikacin impacts kidney function, while acetaminophen (APAP) affects liver function. Combining these drugs may reduce organ damage compared to administering them individually.
Area of Science:
- Pharmacology and Toxicology
- Drug Interactions
- Organ Function Assessment
Background:
- Amikacin is an aminoglycoside antibiotic with known nephrotoxicity.
- Acetaminophen (APAP) is a common analgesic and antipyretic associated with hepatotoxicity.
- Understanding the combined effects of amikacin and APAP on organ function is crucial for patient safety.
Purpose of the Study:
- To investigate the individual and combined effects of amikacin and acetaminophen (APAP) on renal and hepatic function.
- To compare the organ-specific toxicity profiles of amikacin and APAP when administered alone versus simultaneously.
Main Methods:
- Assessment of renal function markers (e.g., creatinine, BUN) following amikacin administration.
- Evaluation of hepatic function markers (e.g., ALT, AST) following APAP administration.
- Comparative analysis of organ function changes in groups receiving drugs individually and in combination.
Main Results:
- Highest doses of amikacin demonstrated significant alterations in renal function.
- Acetaminophen (APAP) exhibited a more pronounced effect on hepatic function.
- Simultaneous administration of amikacin-APAP potentially resulted in fewer organ function changes compared to individual drug administration.
Conclusions:
- Amikacin primarily affects renal function, whereas APAP predominantly impacts hepatic function.
- Combined administration of amikacin and APAP may mitigate the individual organ-specific toxicities observed when drugs are given alone.
- Further research is warranted to elucidate the mechanisms underlying these observed interactions and optimize dosing strategies.
Abstract:
Results suggest that amikacin at the highest dose induces more changes on the renal function while the effect of APAP is more marked on the hepatic function. It might suggest that simultaneous administration of amikacin-APAP produces less changes that when the drugs are administered alone.